SGLT inhibition and euglycaemic diabetic ketoacidosis

被引：66
作者：
Hine, Julia [1 ]
Paterson, Heather [1 ]
Abrol, Esha [1 ]
Russell-Jones, David [1 ]
Herring, Roselle [1 ]
机构：
[1] Royal Surrey Cty Hosp, Dept Endocrinol & Diabet, Cedar Ctr, Guildford GU2 7XX, Surrey, England
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2015年 / 3卷 / 07期
关键词：
D O I：
10.1016/S2213-8587(15)00204-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：503 / 504
页数：3
相关论文
共 7 条
  • [1] Case Reports That Illustrate the Efficacy of SGLT2 Inhibitors in the Type 1 Diabetic Patient
    Bell, David S. H.
    [J]. CASE REPORTS IN ENDOCRINOLOGY, 2015, 2015
  • [2] SGLT inhibition in patients with type 1 diabetes
    Dehn, Clayton A.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (07) : 539 - 539
  • [3] Diabetes mellitus secondary to pancreatic diseases (Type 3c) - Are we neglecting an important disease?
    Ewald, Nils
    Bretzel, Reinhard G.
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2013, 24 (03) : 203 - 206
  • [4] Exploring the Potential of the SGLT2 Inhibitor Dapagliflozin in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
    Henry, Robert R.
    Rosenstock, Julio
    Edelman, Steven
    Mudaliar, Sunder
    Chalamandaris, Alexandros-Georgios
    Kasichayanula, Sreeneeranj
    Bogle, Allyson
    Iqbal, Nayyar
    List, James
    Griffen, Steven C.
    [J]. DIABETES CARE, 2015, 38 (03) : 412 - 419
  • [5] Empagliflozin, a sodium glucose co-transporter 2 inhibitor, in the treatment of type 1 diabetes
    Lamos, Elizabeth M.
    Younk, Lisa M.
    Davis, Stephen N.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (06) : 875 - 882
  • [6] National Institute for Health and Clinical Excellence, 2013, NICE TECHN APPR TA28
  • [7] Sodium- Glucose Cotransporter 2 Inhibition and Glycemic Control in Type 1 Diabetes: Results of an 8-Week Open- Label Proof- ofConcept Trial
    Perkins, Bruce A.
    Cherney, David Z. I.
    Partridge, Helen
    Soleymanlou, Nima
    Tschirhart, Holly
    Zinman, Bernard
    Fagan, Nora M.
    Kaspers, Stefan
    Woerle, Hans-Juergen
    Broedl, Uli C.
    Johansen, Odd-Erik
    [J]. DIABETES CARE, 2014, 37 (05) : 1480 - 1483
1